In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine.

The release of the fourth quarter and full-year 2025 results will serve as a comprehensive health check, moving beyond quarterly performance to evaluate the company's broader strategic pivot. The core ...

Trump, Democrats trade barbs during State of the Union as the president outlines arguments for war with Iran.

CDC leadership shakeup raises concerns about outbreak coordination and guidance hospitals rely on amid director turnover and staff departures.

The Gene Synthesis Market has emerged as one of the most transformative segments within modern biotechnology, driven by rapid ...

The Stanford Emerging Technology Review 2026 describes biotechnology and synthetic biology as emerging general-purpose technologies.

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the ...

One year since the world's strictest lockdown, we take a look at how coronavirus has evolved in India, from the first case on January 30, to the vaccination drive and second wave underway now ...

Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.

Though sparse by New York standards, the prospective offerings are a sharp pickup for an IPO market that’s been mired in a ...